The impact of machine learning techniques in the study of bipolar disorder: A systematic review.

Journal: Neuroscience and biobehavioral reviews
Published Date:

Abstract

Machine learning techniques provide new methods to predict diagnosis and clinical outcomes at an individual level. We aim to review the existing literature on the use of machine learning techniques in the assessment of subjects with bipolar disorder. We systematically searched PubMed, Embase and Web of Science for articles published in any language up to January 2017. We found 757 abstracts and included 51 studies in our review. Most of the included studies used multiple levels of biological data to distinguish the diagnosis of bipolar disorder from other psychiatric disorders or healthy controls. We also found studies that assessed the prediction of clinical outcomes and studies using unsupervised machine learning to build more consistent clinical phenotypes of bipolar disorder. We concluded that given the clinical heterogeneity of samples of patients with BD, machine learning techniques may provide clinicians and researchers with important insights in fields such as diagnosis, personalized treatment and prognosis orientation.

Authors

  • Diego Librenza-Garcia
    Graduation Program in Psychiatry, Universidade Federal das Ciências da Saúde de Porto Alegre, Porto Alegre, RS, Brazil; Bipolar Disorder Program, Laboratory of Molecular Psychiatry, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, RS, 90035-903, Brazil. Electronic address: diegolibrenzagarcia@gmail.com.
  • Bruno Jaskulski Kotzian
    Bipolar Disorder Program, Laboratory of Molecular Psychiatry, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, RS, 90035-903, Brazil. Electronic address: brunokotzian@hotmail.com.
  • Jessica Yang
    University of Texas at Austin College of Pharmacy, United States. Electronic address: jessica.yang10@gmail.com.
  • Benson Mwangi
    Department of Psychiatry and Behavioral Sciences, Center of Excellence on Mood Disorders, Medical School, University of Texas Health Science Center at Houston, USA. Electronic address: Benson.Irungu@uth.tmc.edu.
  • Bo Cao
    Department of Psychiatry, University of Alberta, Edmonton, Canada.
  • Luiza Nunes Pereira Lima
    Bipolar Disorder Program, Laboratory of Molecular Psychiatry, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, RS, 90035-903, Brazil. Electronic address: luiza.npl@gmail.com.
  • Mariane Bagatin Bermudez
    Graduation Program in Psychiatry, Universidade Federal das Ciências da Saúde de Porto Alegre, Porto Alegre, RS, Brazil; Bipolar Disorder Program, Laboratory of Molecular Psychiatry, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, RS, 90035-903, Brazil. Electronic address: mari.bermudez@yahoo.com.br.
  • Manuela Vianna Boeira
    Bipolar Disorder Program, Laboratory of Molecular Psychiatry, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, RS, 90035-903, Brazil. Electronic address: manuelaboeira@yahoo.co.uk.
  • Flávio Kapczinski
    Bipolar Disorder Program and Laboratory of Molecular Psychiatry, Federal University of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.
  • Ives Cavalcante Passos
    Center of Excellence on Mood Disorder, Department of Psychiatry and Behavioral Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA; Bipolar Disorder Program and Laboratory of Molecular Psychiatry, Federal University of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.